In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Synairgen PLC

www.synairgen.com

Latest From Synairgen PLC

Synairgen Developing COPD Treatment To Hold Off Further Viral Damage

UK-based biotech Synairgen spoke to Scrip about the development of its COPD therapy, which is for patients whose lung disease has been exacerbated by the cold or influenza virus.

Respiratory Clinical Trials

Pipeline Watch: Peficitinib, Ubrogepant, Apalutamide Phase III Read-Outs

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Pipeline Watch: Phase III Progress With Esaxerenone, Lusutrombopag

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

PIPELINE WATCH: Progress In Lung And Prostate Cancer, But Interferon Disappoints In Asthma

Pipeline Watch has been updated to bring greater depth and detail to a potential therapeutic product’s progress through the R&D pipeline. The table brings you a snapshot of selected late-stage clinical trial events in the pharma and biotech industries.

Pipeline Watch Research & Development
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Respiratory, Pulmonary
  • Alias(es)
  • SynAIRgen Ltd.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Synairgen PLC
  • Senior Management
  • Richard Marsden, CEO
    John Ward, Dir., Fin.
    Phillip Monk, PhD, CSO
  • Contact Info
  • Synairgen PLC
    Phone: (44) 23 8051 2800
    Mailpoint 810, Level F, Southampton GH
    Tremona Rd.
    Southampton, SO16 6YD
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register